BVT Knock-Out VEEV/ DE000VM554G3 /
2024-11-15 8:32:15 AM | Chg.-0.43 | Bid11:00:34 AM | Ask11:00:34 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.87EUR | -5.18% | 7.90 Bid Size: 4,000 |
8.03 Ask Size: 4,000 |
Veeva Systems Inc | 146.53 USD | 2078-12-31 | Call |
GlobeNewswire
07-01
TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternativ...
GlobeNewswire
05-15
Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion...
GlobeNewswire
01-09
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clini...
GlobeNewswire
2023-10-12
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Ko...
GlobeNewswire
2021-09-16
Litify Continues to Grow at Rapid Scale - Adds High-Profile Customer Experience Leader Hogan Hagy to...
GlobeNewswire
2021-08-03
Explorium Expands Go-to-Market Leadership to Accelerate Adoption of its External Data Platform
GlobeNewswire
2021-06-07
Impel NeuroPharma Announces First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-03-23
Aktana Delivers Intelligent Engagement Solution to Emerging and Mid-sized Life Sciences Companies
GlobeNewswire
2021-02-25
HealthTech Trends 2021: CEO’s of Teladoc, Reliq Health, Relay Medical and Veeva Systems, Driving Rev...
GlobeNewswire
2021-01-20
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
GlobeNewswire
2021-01-12
Leading $2.8 Trillion US Healthcare Market: CEO’s of 1life Healthcare, Skylight Health, Veeva System...
GlobeNewswire
2020-11-05
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire
2020-11-04
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ ...
GlobeNewswire
2020-10-07
Capital Market Laboratories (CMLviz) One on One with Veeva Systems (VEEV) CFO - Move to digital was ...